email page
print pageOncology News
News feed provided by
Aug 27, 2008, 20:00 EDT
- Bortezomib added to melphalan improves myeloma response
- UK's NICE recommends Novartis eye drug Lucentis
- Estrogen receptor-beta status influences breast cancer prognosis
- Postop alcohol withdrawal therapy can help head and neck cancer patients
- Levonorgestrel IUD may increase breast cancer relapse risk in some patients
Oncology News features editorially independent news content provided by Reuters Health. Genentech does not influence and is not involved with the content in this section. More about Reuters Health.
Copyright © 2007: Reuters.
Click for Restrictions
Our commitment to this goal has enabled us to make significant contributions to the understanding of cancer and to translate this understanding into targeted, biologic-based therapies. As part of our commitment, BioOncology.com is dedicated to sharing information and ideas about a new approach to cancer therapy.
Innovative Research Focus
Select any of the research areas below to learn more.
